id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01766297 | 14:24:cancer | negative for malignancy on pathology | 1 | [
"negative",
"for",
"malignancy",
"on",
"pathology"
] | [
0,
0,
3,
0,
0
] |
NCT02012296 | ,26:35:treatment | 2 or more new lesions on bone scan | 1 | [
"2",
"or",
"more",
"new",
"lesions",
"on",
"bone",
"scan"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01940757 | 26:38:chronic_disease,,,, | Laboratory evidence of a coagulopathy (PTT or PT INR greater than 1.1-times the upper reference limit) | 1 | [
"Laboratory",
"evidence",
"of",
"a",
"coagulopathy",
"(",
"PTT",
"or",
"PT",
"INR",
"greater",
"than",
"1.1-times",
"the",
"upper",
"reference",
"limit",
")"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01445821 | 20:45:chronic_disease | Occult or clinical constrictive pericarditis | 1 | [
"Occult",
"or",
"clinical",
"constrictive",
"pericarditis"
] | [
0,
0,
0,
2,
2
] |
NCT02436070 | 61:67:chronic_disease,110:130:chronic_disease,132:140:chronic_disease | Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc | 1 | [
"Presentation",
"to",
"the",
"ED",
"with",
"a",
"chief",
"complaint",
"related",
"to",
"an",
"asthma",
"exacerbation",
"such",
"as",
"shortness",
"of",
"breath",
",",
"respiratory",
"distress",
",",
"wheezing",
",",
"etc"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0
] |
NCT02592707 | 1:13:treatment, | Chemotherapy ≤ 3 months before enrolment | 1 | [
"Chemotherapy",
"≤",
"3",
"months",
"before",
"enrolment"
] | [
1,
0,
0,
0,
0,
0
] |
NCT01908777 | 29:39:treatment | who are deemed eligible for transplant by their treating physician Disease status: CR or PR required | 1 | [
"who",
"are",
"deemed",
"eligible",
"for",
"transplant",
"by",
"their",
"treating",
"physician",
"Disease",
"status",
":",
"CR",
"or",
"PR",
"required"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02257424 | 12:22:cancer, | History of malignancy other than disease under study within 3 years of study enrollment | 1 | [
"History",
"of",
"malignancy",
"other",
"than",
"disease",
"under",
"study",
"within",
"3",
"years",
"of",
"study",
"enrollment"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02324582 | 10:23:treatment,32:41:treatment,43:53:treatment,55:65:treatment,67:77:treatment,82:148:treatment,160:170:treatment,280:289:treatment,294:314:treatment | received prior therapy with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways) including anti-CD40 and anti-OX40 antibodies | 1 | [
"received",
"prior",
"therapy",
"with",
"an",
"anti-PD-1",
",",
"anti-PD-L1",
",",
"anti-PD-L2",
",",
"anti-CD137",
",",
"or",
"anti-Cytotoxic",
"T-lymphocyte-associated",
"antigen-4",
"(",
"CTLA-4",
")",
"antibody",
"(",
"including",
"ipilimumab",
"or",
"any",
"o... | [
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT01890590 | 67:104:cancer,,,171:174:treatment,178:185:treatment | Participants must have histologically or radiological evidence of Stage I (T1N0M0) renal cell carcinoma with a size no larger than 8 cm in greatest dimension measured by MRI or CT Scan | 1 | [
"Participants",
"must",
"have",
"histologically",
"or",
"radiological",
"evidence",
"of",
"Stage",
"I",
"(",
"T1N0M0",
")",
"renal",
"cell",
"carcinoma",
"with",
"a",
"size",
"no",
"larger",
"than",
"8",
"cm",
"in",
"greatest",
"dimension",
"measured",
"by",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT01920061 | 1:35:cancer,37:59:cancer,64:91:cancer,116:160:treatment | castrate resistant prostate cancer, advanced breast cancer, or non-small cell lunch cancer that are candidates for treatment with a docetaxel-based combination | 1 | [
"castrate",
"resistant",
"prostate",
"cancer",
",",
"advanced",
"breast",
"cancer",
",",
"or",
"non-small",
"cell",
"lunch",
"cancer",
"that",
"are",
"candidates",
"for",
"treatment",
"with",
"a",
"docetaxel-based",
"combination"
] | [
3,
3,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT03030118 | 1:60:chronic_disease | Active bacterial, viral, fungal, or opportunistic infection | 1 | [
"Active",
"bacterial",
",",
"viral",
",",
"fungal",
",",
"or",
"opportunistic",
"infection"
] | [
2,
2,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT01595529 | 95:105:treatment | A child whose urine culture reveals an organism that is resistant to the initially prescribed antibiotic | 1 | [
"A",
"child",
"whose",
"urine",
"culture",
"reveals",
"an",
"organism",
"that",
"is",
"resistant",
"to",
"the",
"initially",
"prescribed",
"antibiotic"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02544503 | 13:30:chronic_disease | Moderate or severe depression | 1 | [
"Moderate",
"or",
"severe",
"depression"
] | [
0,
0,
2,
2
] |
NCT02544503 | 8:24:treatment | Normal MRI of the brain | 1 | [
"Normal",
"MRI",
"of",
"the",
"brain"
] | [
0,
1,
1,
1,
1
] |
NCT02091141 | 40:59:treatment,,91:106:cancer,117:134:treatment,137:152:treatment,157:166:treatment,,277:285:chronic_disease,287:304:treatment, | Concurrent administration of any other anti-cancer therapy (except male participants with prostate cancer receiving androgen blockade): Bisphosphonates and denosumab are allowed; Most recent anti-cancer therapy ≤28 days and have not recovered from the side effects, excluding alopecia; Radiation therapy within ≤14 days | 1 | [
"Concurrent",
"administration",
"of",
"any",
"other",
"anti-cancer",
"therapy",
"(",
"except",
"male",
"participants",
"with",
"prostate",
"cancer",
"receiving",
"androgen",
"blockade",
")",
":",
"Bisphosphonates",
"and",
"denosumab",
"are",
"allowed",
";",
"Most",
... | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
3,
0,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
1,
1,
0,
0,
0
] |
NCT02091999 | 21:31:chronic_disease,, | Preexisting sensory neuropathy Grade ≥ 2 | 1 | [
"Preexisting",
"sensory",
"neuropathy",
"Grade",
"≥",
"2"
] | [
0,
0,
2,
0,
0,
0
] |
NCT02287558 | ,39:83:treatment | Recurrent bleeding after at least one previous interventional endoscopic procedure | 1 | [
"Recurrent",
"bleeding",
"after",
"at",
"least",
"one",
"previous",
"interventional",
"endoscopic",
"procedure"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02273375 | 14:35:chronic_disease | known active hepatitis C infection | 1 | [
"known",
"active",
"hepatitis",
"C",
"infection"
] | [
0,
0,
2,
2,
2
] |
NCT02251431 | 1:28:treatment,30:43:treatment,45:58:treatment,69:94:treatment | Implanted cardiac pacemaker, defibrillator, loop recorder, or other implanted metallic device | 1 | [
"Implanted",
"cardiac",
"pacemaker",
",",
"defibrillator",
",",
"loop",
"recorder",
",",
"or",
"other",
"implanted",
"metallic",
"device"
] | [
1,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
1,
1,
1
] |
NCT02836574 | 44:70:treatment | subject is not a good candidate to undergo percutaneous NKA injection, in the judgment of the surgeon or physician who will perform the procedure | 1 | [
"subject",
"is",
"not",
"a",
"good",
"candidate",
"to",
"undergo",
"percutaneous",
"NKA",
"injection",
",",
"in",
"the",
"judgment",
"of",
"the",
"surgeon",
"or",
"physician",
"who",
"will",
"perform",
"the",
"procedure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03026816 | 9:34:chronic_disease | Stable, motor-complete paraplegia | 1 | [
"Stable",
",",
"motor-complete",
"paraplegia"
] | [
0,
0,
2,
2
] |
NCT01617161 | 1:15:treatment,17:43:chronic_disease,47:73:chronic_disease,89:100:chronic_disease,104:109:chronic_disease | Hip prosthesis, inflammatory bowel disease or connective tissue disorder such as active scleroderma or lupus | 1 | [
"Hip",
"prosthesis",
",",
"inflammatory",
"bowel",
"disease",
"or",
"connective",
"tissue",
"disorder",
"such",
"as",
"active",
"scleroderma",
"or",
"lupus"
] | [
1,
1,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
2,
0,
2
] |
NCT02360579 | 113:139:chronic_disease,150:162:treatment,164:185:chronic_disease | Patients who have active medical illness(es) that would pose increased risk for study participation, including: active systemic infections requiring systemic ABX, coagulation disorders, or other active major medical illnesses of the cardiovascular, respiratory, or immune system | 1 | [
"Patients",
"who",
"have",
"active",
"medical",
"illness",
"(",
"es",
")",
"that",
"would",
"pose",
"increased",
"risk",
"for",
"study",
"participation",
",",
"including",
":",
"active",
"systemic",
"infections",
"requiring",
"systemic",
"ABX",
",",
"coagulation... | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02176967 | ,,,51:64:cancer, | > 6 months and < 12 months of age with an adrenal primary tumor < 5 cm in greatest diameter | 1 | [
">",
"6",
"months",
"and",
"<",
"12",
"months",
"of",
"age",
"with",
"an",
"adrenal",
"primary",
"tumor",
"<",
"5",
"cm",
"in",
"greatest",
"diameter"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02955537 | 1:13:chronic_disease | Hypertensive | 1 | [
"Hypertensive"
] | [
2
] |
NCT02940288 | 19:30:treatment | Patients naïve to acupuncture | 1 | [
"Patients",
"naïve",
"to",
"acupuncture"
] | [
0,
0,
0,
1
] |
NCT03168347 | 16:25:chronic_disease | Diagnosed with psoriasis (ICD-9: 696.1) | 1 | [
"Diagnosed",
"with",
"psoriasis",
"(",
"ICD-9",
":",
"696.1",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02547818 | 1:23:treatment, | Investigational agents are prohibited one month prior to entry and for the duration of the trial | 1 | [
"Investigational",
"agents",
"are",
"prohibited",
"one",
"month",
"prior",
"to",
"entry",
"and",
"for",
"the",
"duration",
"of",
"the",
"trial"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02937402 | 1:29:treatment,31:41:treatment,43:53:treatment,55:65:treatment,70:90:treatment,102:112:treatment,166:172:cancer | Prior therapy with anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways) | 1 | [
"Prior",
"therapy",
"with",
"anti-PD-1",
",",
"anti-PD-L1",
",",
"anti-PD-L2",
",",
"anti-CD137",
",",
"or",
"anti-CTLA-4",
"antibody",
"(",
"including",
"ipilimumab",
"or",
"any",
"other",
"antibody",
"or",
"drug",
"specifically",
"targeting",
"T-cell",
"co-stimu... | [
1,
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02991651 | 12:28:chronic_disease | ongoing or active infection | 1 | [
"ongoing",
"or",
"active",
"infection"
] | [
0,
0,
2,
2
] |
NCT03004807 | 1:12:chronic_disease,, | Head injury with loss of consciousness of > 5 minutes in the last 5 years | 1 | [
"Head",
"injury",
"with",
"loss",
"of",
"consciousness",
"of",
">",
"5",
"minutes",
"in",
"the",
"last",
"5",
"years"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01620216 | 26:34:cancer,65:97:cancer,101:135:cancer | with relapsed/refractory leukemia with a confirmed diagnosis of acute myelogenous leukemia (AML) or acute lymphoblastic leukemia (ALL) | 1 | [
"with",
"relapsed/refractory",
"leukemia",
"with",
"a",
"confirmed",
"diagnosis",
"of",
"acute",
"myelogenous",
"leukemia",
"(",
"AML",
")",
"or",
"acute",
"lymphoblastic",
"leukemia",
"(",
"ALL",
")"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01869114 | 1:4:cancer,8:11:cancer,30:60:treatment,49:60:treatment | MDS or AML as above BUT with prior therapy with Azacitibine (Arm C): Patients who meet criteria for either Arm A or Arm B but have been treated or are currently treated with Azacitibine | 1 | [
"MDS",
"or",
"AML",
"as",
"above",
"BUT",
"with",
"prior",
"therapy",
"with",
"Azacitibine",
"(",
"Arm",
"C",
")",
":",
"Patients",
"who",
"meet",
"criteria",
"for",
"either",
"Arm",
"A",
"or",
"Arm",
"B",
"but",
"have",
"been",
"treated",
"or",
"are",... | [
3,
0,
3,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01869114 | 96:105:treatment | Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing | 1 | [
"Patients",
"must",
"be",
"able",
"to",
"sign",
"consent",
"and",
"be",
"willing",
"and",
"able",
"to",
"comply",
"with",
"scheduled",
"visits",
",",
"treatment",
"plan",
"and",
"laboratory",
"testing"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02291523 | 37:46:treatment,,65:70:treatment,72:80:treatment,84:100:treatment | Children with recent dose change of biologics (within 4 weeks), 5-ASA, steroids or immunomodulators (within 4 weeks) | 1 | [
"Children",
"with",
"recent",
"dose",
"change",
"of",
"biologics",
"(",
"within",
"4",
"weeks",
")",
",",
"5-ASA",
",",
"steroids",
"or",
"immunomodulators",
"(",
"within",
"4",
"weeks",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0
] |
NCT02233868 | 1:15:treatment | anticoagulants | 1 | [
"anticoagulants"
] | [
1
] |
NCT03088592 | 47:57:chronic_disease,, | Currently uncontrolled clinically significant depression (BDI>20) | 1 | [
"Currently",
"uncontrolled",
"clinically",
"significant",
"depression",
"(",
"BDI",
">",
"20",
")"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02960113 | 1:15:chronic_disease | Coagulopathies | 1 | [
"Coagulopathies"
] | [
2
] |
NCT01367444 | 33:42:treatment | Enrolment in any other clinical treatment study throughout the duration of the SAR422459 study | 1 | [
"Enrolment",
"in",
"any",
"other",
"clinical",
"treatment",
"study",
"throughout",
"the",
"duration",
"of",
"the",
"SAR422459",
"study"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01817751 | 29:44:treatment, | Fixed or decreasing dose of corticosteroids (or no corticosteroids) for at least 1 week prior to cycle 1 day 1 | 1 | [
"Fixed",
"or",
"decreasing",
"dose",
"of",
"corticosteroids",
"(",
"or",
"no",
"corticosteroids",
")",
"for",
"at",
"least",
"1",
"week",
"prior",
"to",
"cycle",
"1",
"day",
"1"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02158793 | ,,41:51:treatment,,,, | Negative pregnancy test within 48hrs of transplant for women of childbearing age and who agree to use a reliable form of contraception for one year following transplant | 1 | [
"Negative",
"pregnancy",
"test",
"within",
"48hrs",
"of",
"transplant",
"for",
"women",
"of",
"childbearing",
"age",
"and",
"who",
"agree",
"to",
"use",
"a",
"reliable",
"form",
"of",
"contraception",
"for",
"one",
"year",
"following",
"transplant"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02862210 | 18:34:chronic_disease,38:51:chronic_disease,55:79:chronic_disease | The diagnosis of bipolar disorder or schizophrenia or schizoaffective disorder | 1 | [
"The",
"diagnosis",
"of",
"bipolar",
"disorder",
"or",
"schizophrenia",
"or",
"schizoaffective",
"disorder"
] | [
0,
0,
0,
2,
2,
0,
2,
0,
2,
2
] |
NCT02446457 | ,,106:116:treatment | have a negative urine or serum pregnancy test within 72 hours prior to receiving the first dose of study medication | 1 | [
"have",
"a",
"negative",
"urine",
"or",
"serum",
"pregnancy",
"test",
"within",
"72",
"hours",
"prior",
"to",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"medication"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02102113 | 21:30:treatment | Current or lifetime treatment | 1 | [
"Current",
"or",
"lifetime",
"treatment"
] | [
0,
0,
0,
1
] |
NCT01912612 | 14:35:chronic_disease | Uncontrolled narrow-angle glaucoma | 1 | [
"Uncontrolled",
"narrow-angle",
"glaucoma"
] | [
0,
2,
2
] |
NCT02535312 | 16:22:treatment,118:136:treatment,,,,,,,425:436:treatment | The effects of TRC102 on the developing human fetus are unknown; for this reason and because TRC102 as well as other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and 4 months after completion of the study drugs | 1 | [
"The",
"effects",
"of",
"TRC102",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
";",
"for",
"this",
"reason",
"and",
"because",
"TRC102",
"as",
"well",
"as",
"other",
"therapeutic",
"agents",
"used",
"in",
"this",
"trial",
"are",
"known",
... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0... |
NCT00075387 | ,114:138:chronic_disease | Subjects with uncontrolled (over the last 30 days) clinically significant confounding medical conditions such as congestive heart failure | 1 | [
"Subjects",
"with",
"uncontrolled",
"(",
"over",
"the",
"last",
"30",
"days",
")",
"clinically",
"significant",
"confounding",
"medical",
"conditions",
"such",
"as",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01849146 | 20:30:cancer,57:62:cancer,66:101:cancer,105:136:cancer,138:144:cancer,149:156:cancer | have no concurrent malignancy except curatively treated basal or squamous cell carcinoma of the skin or carcinoma in situ of the cervix, breast, or bladder | 1 | [
"have",
"no",
"concurrent",
"malignancy",
"except",
"curatively",
"treated",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"or",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"breast",
",",
"or",
"bladder"
] | [
0,
0,
0,
3,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
0,
0,
3
] |
NCT02594501 | 56:59:allergy_name,61:72:allergy_name,74:82:allergy_name | Known allergy or intolerance to the study medications: ASA, clopidogrel, coumadin and its derivatives | 1 | [
"Known",
"allergy",
"or",
"intolerance",
"to",
"the",
"study",
"medications",
":",
"ASA",
",",
"clopidogrel",
",",
"coumadin",
"and",
"its",
"derivatives"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
4,
0,
0,
0
] |
NCT00948285 | 15:28:cancer,,, | Patients with breast cancer diagnosis during pregnancy (women who could bear children must have a negative pregnancy test before beginning this study) | 1 | [
"Patients",
"with",
"breast",
"cancer",
"diagnosis",
"during",
"pregnancy",
"(",
"women",
"who",
"could",
"bear",
"children",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"before",
"beginning",
"this",
"study",
")"
] | [
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02542657 | 1:10:treatment,21:24:chronic_disease,36:52:treatment, | Treatment sensitive HIV and, if on anti-HIV therapy, HIV viral load < 50 copies/mm^3 | 1 | [
"Treatment",
"sensitive",
"HIV",
"and",
",",
"if",
"on",
"anti-HIV",
"therapy",
",",
"HIV",
"viral",
"load",
"<",
"50",
"copies/mm^3"
] | [
1,
0,
2,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01817751 | 1:24:chronic_disease,51:72:chronic_disease,74:98:chronic_disease,110:136:chronic_disease,,161:176:treatment | Arterial thromboembolic or embolic events such as myocardial infarction, cerebrovascular accident, including transient ischemic attacks 6 months prior to first study treatment | 1 | [
"Arterial",
"thromboembolic",
"or",
"embolic",
"events",
"such",
"as",
"myocardial",
"infarction",
",",
"cerebrovascular",
"accident",
",",
"including",
"transient",
"ischemic",
"attacks",
"6",
"months",
"prior",
"to",
"first",
"study",
"treatment"
] | [
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1
] |
NCT02047474 | 36:46:cancer | There is no evidence of the second malignancy at the time of study entry | 1 | [
"There",
"is",
"no",
"evidence",
"of",
"the",
"second",
"malignancy",
"at",
"the",
"time",
"of",
"study",
"entry"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT01293214 | 10:20:treatment | Level of amputation anywhere from the wrist (or ankle) joint to just below the shoulder (or hip) joint, which should be functional | 1 | [
"Level",
"of",
"amputation",
"anywhere",
"from",
"the",
"wrist",
"(",
"or",
"ankle",
")",
"joint",
"to",
"just",
"below",
"the",
"shoulder",
"(",
"or",
"hip",
")",
"joint",
",",
"which",
"should",
"be",
"functional"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02261519 | 49:72:chronic_disease,74:95:chronic_disease,97:113:chronic_disease,115:140:chronic_disease,142:166:chronic_disease,168:193:chronic_disease,195:212:chronic_disease,214:258:chronic_disease,260:268:chronic_disease,292:308:chronic_disease | Meets the DSM-IV or V criteria at screening for intellectual disability, dissociative disorder, bipolar disorder, major depressive disorder, schizoaffective disorder, schizophreniform disorder, autistic disorder, primary substance-induced psychotic disorder, dementia, or any other comorbid mental disorders that in the opinion of the Investigator may interfere with study conduct and results interpretation | 1 | [
"Meets",
"the",
"DSM-IV",
"or",
"V",
"criteria",
"at",
"screening",
"for",
"intellectual",
"disability",
",",
"dissociative",
"disorder",
",",
"bipolar",
"disorder",
",",
"major",
"depressive",
"disorder",
",",
"schizoaffective",
"disorder",
",",
"schizophreniform",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02995330 | 1:19:treatment,21:30:treatment,32:43:treatment,49:83:cancer | Prior chemotherapy (docetaxel, cabazitaxel) for castrate resistant prostate cancer | 1 | [
"Prior",
"chemotherapy",
"(",
"docetaxel",
",",
"cabazitaxel",
")",
"for",
"castrate",
"resistant",
"prostate",
"cancer"
] | [
1,
1,
0,
1,
0,
1,
0,
0,
3,
3,
3,
3
] |
NCT02232165 | 38:52:allergy_name | Allergy or other contraindication to norepinephrine | 1 | [
"Allergy",
"or",
"other",
"contraindication",
"to",
"norepinephrine"
] | [
0,
0,
0,
0,
0,
4
] |
NCT02407028 | 39:46:chronic_disease | Coma suspected to de due to primarily non-TBI causes | 1 | [
"Coma",
"suspected",
"to",
"de",
"due",
"to",
"primarily",
"non-TBI",
"causes"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02227199 | 1:25:chronic_disease | congestive heart failure | 1 | [
"congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02129348 | 1:27:chronic_disease, | glomerular filtration rate less than 44ml/min/ 1.73m2 | 1 | [
"glomerular",
"filtration",
"rate",
"less",
"than",
"44ml/min/",
"1.73m2"
] | [
2,
2,
2,
0,
0,
0,
0
] |
NCT02507687 | 1:12:treatment,24:40:treatment,49:66:treatment, | Eye surgery (including cataract surgery) and or eye laser surgery within the past 6 months | 1 | [
"Eye",
"surgery",
"(",
"including",
"cataract",
"surgery",
")",
"and",
"or",
"eye",
"laser",
"surgery",
"within",
"the",
"past",
"6",
"months"
] | [
1,
1,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03179397 | 10:25:treatment | Previous corneal surgery | 1 | [
"Previous",
"corneal",
"surgery"
] | [
0,
1,
1
] |
NCT01791543 | 7:34:treatment,63:84:chronic_disease,86:94:chronic_disease | prior antiarrhythmic drug therapy has failed due to recurrent ventricular arrythmia, toxicity, or intolerance | 1 | [
"prior",
"antiarrhythmic",
"drug",
"therapy",
"has",
"failed",
"due",
"to",
"recurrent",
"ventricular",
"arrythmia",
",",
"toxicity",
",",
"or",
"intolerance"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0
] |
NCT03001882 | 46:64:chronic_disease | Participants with active, known or suspected autoimmune disease | 1 | [
"Participants",
"with",
"active",
",",
"known",
"or",
"suspected",
"autoimmune",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03062462 | 1:43:chronic_disease | severe congestive heart failure NYHA II-IV | 1 | [
"severe",
"congestive",
"heart",
"failure",
"NYHA",
"II-IV"
] | [
2,
2,
2,
2,
2,
2
] |
NCT02805504 | 12:23:allergy_name | Allergy to bupivacaine | 1 | [
"Allergy",
"to",
"bupivacaine"
] | [
0,
0,
4
] |
NCT02219555 | 1:12:chronic_disease | sarcoidosis | 1 | [
"sarcoidosis"
] | [
2
] |
NCT02473250 | 1:14:chronic_disease | renal failure | 1 | [
"renal",
"failure"
] | [
2,
2
] |
NCT02593123 | 1:33:cancer | Acute myelogenous leukemia (AML) | 1 | [
"Acute",
"myelogenous",
"leukemia",
"(",
"AML",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02408861 | 40:51:cancer,120:129:treatment,139:147:cancer,149:157:cancer,163:208:cancer | For participants in the 24 participant solid tumor cohort, only those histologies not known to respond to single agent nivolumab (such as pancreas, prostate, and microsatellite stable [MSS] colorectal cancer) | 1 | [
"For",
"participants",
"in",
"the",
"24",
"participant",
"solid",
"tumor",
"cohort",
",",
"only",
"those",
"histologies",
"not",
"known",
"to",
"respond",
"to",
"single",
"agent",
"nivolumab",
"(",
"such",
"as",
"pancreas",
",",
"prostate",
",",
"and",
"micr... | [
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
3,
0,
3,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0
] |
NCT02522715 | 1:10:treatment | Flutamide; approximate half-life: 6 hours; washout period required: 36 hours | 1 | [
"Flutamide",
";",
"approximate",
"half-life",
":",
"6",
"hours",
";",
"washout",
"period",
"required",
":",
"36",
"hours"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01050855 | 8:32:cancer | severe Langerhans histiocytosis | 1 | [
"severe",
"Langerhans",
"histiocytosis"
] | [
0,
3,
3
] |
NCT02140255 | 24:28:treatment, | Mother did not receive ARVs during the current pregnancy per criteria above | 1 | [
"Mother",
"did",
"not",
"receive",
"ARVs",
"during",
"the",
"current",
"pregnancy",
"per",
"criteria",
"above"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01572480 | ,59:62:cancer,,, | Progressive increase in M protein level (evolving type of SMM; increase in serum M protein by greater than or equal to 25% on 2 successive evaluations within a 6-month period) | 1 | [
"Progressive",
"increase",
"in",
"M",
"protein",
"level",
"(",
"evolving",
"type",
"of",
"SMM",
";",
"increase",
"in",
"serum",
"M",
"protein",
"by",
"greater",
"than",
"or",
"equal",
"to",
"25",
"%",
"on",
"2",
"successive",
"evaluations",
"within",
"a",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02101736 | 1:39:treatment,94:113:chronic_disease,203:217:treatment | Concomitant treatment with medications that prolong the QT interval and have a known risk of Torsades de Pointes is not contraindicated, but should be avoided if possible and will require more frequent EKG monitoring | 1 | [
"Concomitant",
"treatment",
"with",
"medications",
"that",
"prolong",
"the",
"QT",
"interval",
"and",
"have",
"a",
"known",
"risk",
"of",
"Torsades",
"de",
"Pointes",
"is",
"not",
"contraindicated",
",",
"but",
"should",
"be",
"avoided",
"if",
"possible",
"and... | [
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02070549 | 5:18:treatment,30:42:treatment,44:56:treatment,44:78:treatment,80:96:treatment,101:114:treatment,, | Any major surgery, extensive radiotherapy, chemotherapy with delayed toxicity, biologic therapy, or immunotherapy within 28 days prior to enrollment and/or daily or weekly chemotherapy without the potential for delayed toxicity within 14 days prior to enrollment | 1 | [
"Any",
"major",
"surgery",
",",
"extensive",
"radiotherapy",
",",
"chemotherapy",
"with",
"delayed",
"toxicity",
",",
"biologic",
"therapy",
",",
"or",
"immunotherapy",
"within",
"28",
"days",
"prior",
"to",
"enrollment",
"and/or",
"daily",
"or",
"weekly",
"chem... | [
0,
1,
1,
0,
0,
1,
0,
1,
1,
1,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02546583 | ,,46:56:treatment | Study Visit 1 loop diuretic dose ≤ 160 mg of furosemide equivalents | 1 | [
"Study",
"Visit",
"1",
"loop",
"diuretic",
"dose",
"≤",
"160",
"mg",
"of",
"furosemide",
"equivalents"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02570672 | 11:21:chronic_disease,, | Untreated depression or Geriatric Depression Scale score on 15-item scale >7 | 1 | [
"Untreated",
"depression",
"or",
"Geriatric",
"Depression",
"Scale",
"score",
"on",
"15-item",
"scale",
">",
"7"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02414269 | 1:14:cancer,15:25:cancer,95:102:treatment | Breast cancer metastatic to the pleura that extends outside of the pleura requiring immediate therapy | 1 | [
"Breast",
"cancer",
"metastatic",
"to",
"the",
"pleura",
"that",
"extends",
"outside",
"of",
"the",
"pleura",
"requiring",
"immediate",
"therapy"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03170453 | 1:23:chronic_disease | Organic brain syndrome | 1 | [
"Organic",
"brain",
"syndrome"
] | [
2,
2,
2
] |
NCT00467987 | 5:23:cancer | h/o prostate carcinoma | 1 | [
"h/o",
"prostate",
"carcinoma"
] | [
0,
3,
3
] |
NCT02250157 | ,,,,187:189:treatment | Sexually active male subjects must use a barrier method of contraception during the study and agree to continue the use of male contraception for at least 30 days after the last dose of IP | 1 | [
"Sexually",
"active",
"male",
"subjects",
"must",
"use",
"a",
"barrier",
"method",
"of",
"contraception",
"during",
"the",
"study",
"and",
"agree",
"to",
"continue",
"the",
"use",
"of",
"male",
"contraception",
"for",
"at",
"least",
"30",
"days",
"after",
"t... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02213289 | 28:38:cancer | No currently active second malignancy | 1 | [
"No",
"currently",
"active",
"second",
"malignancy"
] | [
0,
0,
0,
0,
3
] |
NCT02584647 | 32:37:cancer,41:76:cancer,78:109:cancer, | Examples of the latter include basal or squamous cell carcinoma of the skin, in-situ carcinoma of the cervix, and isolated elevation of prostate-specific antigen | 1 | [
"Examples",
"of",
"the",
"latter",
"include",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"in-situ",
"carcinoma",
"of",
"the",
"cervix",
",",
"and",
"isolated",
"elevation",
"of",
"prostate-specific",
"antigen"
] | [
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02950337 | 12:28:chronic_disease | ongoing or active infection | 1 | [
"ongoing",
"or",
"active",
"infection"
] | [
0,
0,
2,
2
] |
NCT02578641 | 1:4:chronic_disease | HIV Positive | 1 | [
"HIV",
"Positive"
] | [
2,
0
] |
NCT02303977 | 1:21:treatment,38:67:treatment,77:88:treatment,92:101:treatment,173:183:treatment,185:194:treatment,196:207:treatment,209:220:treatment,222:232:treatment,237:246:treatment | First-line treatment with a standard platinum doublet chemotherapy regimen (carboplatin or cisplatin at standard dosing plus one of the following drugs at standard dosing: paclitaxel, docetaxel, vinblastine, vinorelbine, pemetrexed, or etoposide) | 1 | [
"First-line",
"treatment",
"with",
"a",
"standard",
"platinum",
"doublet",
"chemotherapy",
"regimen",
"(",
"carboplatin",
"or",
"cisplatin",
"at",
"standard",
"dosing",
"plus",
"one",
"of",
"the",
"following",
"drugs",
"at",
"standard",
"dosing",
":",
"paclitaxel"... | [
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0
] |
NCT02592551 | ,,,,,,,,,,,,,,,,,,334:350:cancer | Hemoglobin ≥ 9.0 g/dL Absolute neutrophil count (ANC) ≥ 1.5 × 109/L (> 1500 per mm3) Platelet count ≥ 100 × 109/L (>100,000 per mm3) Serum bilirubin ≤ 1.5× institutional upper limit of normal (ULN)AST<3.0 Creatinine clearance >50mL/miN Aspartate transaminase (AST) and alanine transaminase (ALT) ≤ 2.5 × ULN (≤ 5 × ULN if documented liver metastasis are present) | 1 | [
"Hemoglobin",
"≥",
"9.0",
"g/dL",
"Absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
"≥",
"1.5",
"×",
"109/L",
"(",
">",
"1500",
"per",
"mm3",
")",
"Platelet",
"count",
"≥",
"100",
"×",
"109/L",
"(",
">",
"100,000",
"per",
"mm3",
")",
"Serum",
"bili... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02471430 | 12:73:treatment | History of solid organ transplantation with an existing functional graft | 1 | [
"History",
"of",
"solid",
"organ",
"transplantation",
"with",
"an",
"existing",
"functional",
"graft"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02442102 | 1:29:treatment,37:47:treatment,49:60:treatment | Prior major thoracic surgery (e.g., sternotomy, thoracotomy) | 1 | [
"Prior",
"major",
"thoracic",
"surgery",
"(",
"e.g.",
",",
"sternotomy",
",",
"thoracotomy",
")"
] | [
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0
] |
NCT02857218 | 1:35:chronic_disease,57:91:treatment,136:164:treatment,170:181:treatment | Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with ferumoxytol | 1 | [
"Human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-positive",
"patients",
"on",
"combination",
"antiretroviral",
"therapy",
"are",
"ineligible",
"because",
"of",
"the",
"potential",
"for",
"pharmacokinetic",
"interactions",
"with",
"ferumoxytol"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1
] |
NCT02313428 | 11:20:chronic_disease,32:37:chronic_disease,44:54:chronic_disease,58:71:chronic_disease | Untreated infection at site of ulcer (i.e. cellulitis or osteomyelitis) | 1 | [
"Untreated",
"infection",
"at",
"site",
"of",
"ulcer",
"(",
"i.e",
".",
"cellulitis",
"or",
"osteomyelitis",
")"
] | [
0,
2,
0,
0,
0,
2,
0,
0,
0,
2,
0,
2,
0
] |
NCT02503722 | 13:29:chronic_disease | Significant valvular disease | 1 | [
"Significant",
"valvular",
"disease"
] | [
0,
2,
2
] |
NCT02905370 | 1:17:chronic_disease | Terminal illness | 1 | [
"Terminal",
"illness"
] | [
2,
2
] |
NCT01643473 | 6:31:chronic_disease,,,,,144:152:chronic_disease,156:170:chronic_disease,,,,227:230:chronic_disease,253:267:chronic_disease | Have uncontrolled hypertension defined as BP>140/90 mmHg on at least two consecutive visits in the past year (or BP>130/80 mmHg for those with diabetes or kidney disease) and Framingham Risk Scores (FRS) >20% (or at least one CVD risk factor including hyperlipidemia or diabetes) | 1 | [
"Have",
"uncontrolled",
"hypertension",
"defined",
"as",
"BP",
">",
"140/90",
"mmHg",
"on",
"at",
"least",
"two",
"consecutive",
"visits",
"in",
"the",
"past",
"year",
"(",
"or",
"BP",
">",
"130/80",
"mmHg",
"for",
"those",
"with",
"diabetes",
"or",
"kidne... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
2,
0,
0,
0
] |
NCT02094794 | 1:13:treatment, | Chemotherapy given within 14 days of planned study enrollment for the purpose of controlling counts is permitted | 1 | [
"Chemotherapy",
"given",
"within",
"14",
"days",
"of",
"planned",
"study",
"enrollment",
"for",
"the",
"purpose",
"of",
"controlling",
"counts",
"is",
"permitted"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02473250 | 1:11:cancer | malignancy | 1 | [
"malignancy"
] | [
3
] |
NCT02433210 | 1:19:chronic_disease,56:63:chronic_disease,65:78:chronic_disease,80:89:chronic_disease | Medical conditions which may interfere with the study (cardiac, liver disease, Hepatitis) | 1 | [
"Medical",
"conditions",
"which",
"may",
"interfere",
"with",
"the",
"study",
"(",
"cardiac",
",",
"liver",
"disease",
",",
"Hepatitis",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
0
] |
NCT01597518 | 1:12:treatment | Montelukast | 1 | [
"Montelukast"
] | [
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.